Furthermore, P4 treatment promoted apoptosis by upregulating BAX and p53 and downregulating BCL-2.<h4>Conclusion</h4>Progesterone can counteract estrogen-driven breast cancer progression in ER+/PR+ cells by inhibiting proliferation, reversing the EMT process, and inducing apoptosis. Here, BCL2 is linked to breast cancer.